Compare Costco Wholesale Corporation (COST) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Costco Wholesale Corporation vs Heron Therapeutics Inc — how do they compare? Costco Wholesale Corporation trades at $921.77 (market cap $408.78B), while Heron Therapeutics Inc trades at $0.46 (market cap $82.52M). The key difference: Costco Wholesale Corporation is far larger — about 4953.7× Heron Therapeutics Inc's market cap, and Costco Wholesale Corporation pays a 0.64% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| COST | HRTX | |
|---|---|---|
Market Cap | $408.78B | $82.52M |
Sector | Consumer Staples | Health |
52-Week High | $1.09K | $2.04 |
52-Week Low | $849.63 | $0.39 |
Enterprise Value | $396.92B | $180.42M |
Dividend Yield | 0.64% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
COST trades at $926.43, up 1.11% today, with a bearish technical signal but strong fundamentals. Revenue grew to $275.24B in 2025, with net income up to $8.10B, and March 2026 sales surged 11.3% year-over-year (Costco report, April 8, 2026). Valuation ratios are elevated, with a P/E of 46.6, while analyst consensus is bullish with a $1,120 price target. Recent membership fee hikes and institutional buying support growth prospects.
Outlook remains positive due to steady revenue growth and high membership renewal rates, but risks include rich valuations and competitive pressures. The stock offers long-term value if pullbacks occur, with earnings momentum key for upside. Bearish technicals suggest near-term caution, though fundamentals underpin investor confidence.
HRTX trades at $0.42 with a slight 0.6% daily gain, but technical indicators show a bearish trend with moving averages signaling sell pressure. The company reported Q1 2026 revenue of $151M with a net loss of $31M, continuing negative profitability trends. Recent news highlights patent litigation developments and management reaffirming full-year guidance despite quarterly misses.
While analyst consensus remains overwhelmingly bullish (95% buy ratings), fundamental challenges persist with negative earnings and cash flow. Investment opportunity exists if the company can achieve profitability turnaround, but risks include ongoing operational losses, competitive pressures in biotechnology, and patent litigation uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Costco Wholesale Corporation
The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet
Read more on COST →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
